Click to enlarge
99% Raw Material Ritlecitinib Pharmaceutical Powder CAS 1792180-81-4
China BeijingBeijing Mesochem Technology Co., Ltd.
US$1.00 - 10.00
MOQ1 g
Product profile
- Function
- Hormones and Regulation of Endocrine Function of Drug, Vitamins and Minerals Deficiency Drug, Nutritional Therapeutics, Antineoplastic, Antibiotic and Antimicrobial Agents, Antiparasitic, Antipyretic Analgesic and Non-Steroidal Anti-Inflammatory Analgesic, Immune System Drugs, Specialist Drugs, Regulating Water and Salt, Electrolyte and Acid-Base Balance of Medicine, Drug Detoxification, Diagnostic Agents, Anesthetic and Adjuvant, Nervous System Drugs, Blood System Agents, Enzymes and Other Biochemical, Drug Treatment of Mental Disorder, Visceral System Medication, Central Nervous System Agents, Cardiovascular Agents, Anti-Allergic Agents, Urinary System Agents, Antidote, Respiratory System Agents, Disinfectant and Preservatives
- Certification
- Reach
- Grade Standard
- Medicine Grade
- Type
- Chemical Reagent
- State
- Solid
- Molecular Formula
- C17h14brn3o2s
- CAS Registry Number
- 1792180-81-4
- Form
- Powder
- Assay
- 99%
- Color
- White
Company profile
Beijing Mesochem Technology Co., Ltd.
北京迈索化学技术有限公司China BeijingFloor 23, Building 9, Lippo Plaza, Ecouomic and Techenological Decelopment Zone, Beijin, Beijing, China- Business Type: Combined
- Established: 2009
- Employees: 35
- Plant Area: 800.0m²
- Avg. Response Time: ≤ 4.68h
- System Certification: ISO9001:2015 certificate
Main Products
- Adapalene
- Lorcaserin Hydrochloride
- Tofacitinib Citrate
- Avanafil
- Baricitinib
- Brivaracetam
- Crisaborole
- Lesinurad
- Osimertinib Mesylate
- Empagliflozin
Main Markets
South America,Africa,Southeast Asia/ Mideast,East Asia(Japan/ South Korea),Domestic,Europe,Australia,North America
